Antipsychotic Augmentation vs Monotherapy in Schizophrenia

Slideshow

To augment or not to augment? That is the question.

View the slides in PDF format. Also see: Antipsychotics and Breast Cancer Risk.

Related Videos
Experts on MDD.
Experts on MDD.
Related Content

Phase 3 Study Supports Efficacy, Safety of New Chemical Entity for MDD

September 20th 2023

Here's to a Psychedelic Revolution

April 9th 2022

Girls and Their Monsters, Part 3

September 18th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Developing Effective Treatment Strategies for Women With Schizophrenia

September 15th 2023

Special Populations Research Roundup: September 15

September 15th 2023

Phase 3 Study Supports Efficacy, Safety of New Chemical Entity for MDD

September 20th 2023

Here's to a Psychedelic Revolution

April 9th 2022

Girls and Their Monsters, Part 3

September 18th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Developing Effective Treatment Strategies for Women With Schizophrenia

September 15th 2023

Special Populations Research Roundup: September 15

September 15th 2023

Phase 3 Study Supports Efficacy, Safety of New Chemical Entity for MDD

September 20th 2023

Here's to a Psychedelic Revolution

April 9th 2022

Girls and Their Monsters, Part 3

September 18th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Developing Effective Treatment Strategies for Women With Schizophrenia

September 15th 2023

Special Populations Research Roundup: September 15

September 15th 2023
© 2023 MJH Life Sciences

All rights reserved.